Heartflow, Inc. Common Stock (HTFL) EBITDA Yield: History & Chart

Heartflow, Inc. Common Stock(HTFL)

Medical - Healthcare Information Services · San Francisco, CA

$51.40-0.81 (-1.55%)

Delayed quote: Oct 6, 2026, 12:55 PM EDT

About Heartflow, Inc. Common Stock

HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.

San Francisco, CA

843 employees

www.heartflow.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: John Farquhar

View full financials

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Heartflow, Inc. Common Stock (HTFL)	$4.43B	N/A	N/A	N/A	N/A
Adaptive Biotechnologies Corporation (ADPT)vs ›	$4.41B	N/A	N/A	N/A	N/A
Indivior Pharmaceuticals Inc (INDV)vs ›	$4.40B	11.37%	8.95%	6.39%	6.78%
Edgewise Therapeutics, Inc. (EWTX)vs ›	$4.28B	N/A	N/A	N/A	N/A
BillionToOne, Inc. (BLLN)vs ›	$4.63B	1.32%	0.79%	0.79%	0.79%
Option Care Health, Inc. (OPCH)vs ›	$4.66B	7.15%	7.73%	6.77%	5.88%
Definium Therapeutics, Inc. (DFTX)vs ›	$4.66B	N/A	N/A	N/A	N/A
LivaNova PLC (LIVN)vs ›	$4.15B	6.14%	6.89%	5.07%	4.64%
LifeStance Health Group, Inc. (LFST)vs ›	$4.67B	2.86%	2.61%	2.07%	1.96%
Dianthus Therapeutics, Inc. (DNTH)vs ›	$4.71B	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EBITDA YIELD

TTM

Heartflow, Inc. Common Stock (HTFL)

$4.43B

N/A

Adaptive Biotechnologies Corporation (ADPT)vs ›

$4.41B

N/A

Indivior Pharmaceuticals Inc (INDV)vs ›

$4.40B

11.37%

8.95%

6.39%

6.78%

Edgewise Therapeutics, Inc. (EWTX)vs ›

$4.28B

N/A

BillionToOne, Inc. (BLLN)vs ›

$4.63B

1.32%

0.79%

Option Care Health, Inc. (OPCH)vs ›

$4.66B

7.15%

7.73%

6.77%

5.88%

Definium Therapeutics, Inc. (DFTX)vs ›

$4.66B

N/A

LivaNova PLC (LIVN)vs ›

$4.15B

6.14%

6.89%

5.07%

4.64%

LifeStance Health Group, Inc. (LFST)vs ›

$4.67B

2.86%

2.61%

2.07%

1.96%

Dianthus Therapeutics, Inc. (DNTH)vs ›

$4.71B

N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

EBITDA Yield: N/A

HTFL EBITDA Yield Metrics

HTFL Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics